Latest Articles
Association Between Previous Surgical Treatment and Outcomes of Repeat Endometriosis Surgery - medtalks.in
Association Between Previous Surgical Treatment and Outcomes of Repeat Endometriosis Surgery medtalks.in
Published: Nov. 6, 2025, 11:13 a.m.
Is There Really a Cancer Epidemic in Younger Adults? - Medscape
Is There Really a Cancer Epidemic in Younger Adults? Medscape
Published: Nov. 6, 2025, 10:07 a.m.
Endometriosis Market to Reach USD 3.93 Billion by 2032 Driven by Growing Awareness - newstrail.com
Endometriosis Market to Reach USD 3.93 Billion by 2032 Driven by Growing Awareness newstrail.com
Published: Nov. 6, 2025, 9:31 a.m.
Why TriCo Bancshares stock is popular among millennials - 2025 Buyback Activity & Consistent Return Investment Signals - fcp.pa.gov.br
Why TriCo Bancshares stock is popular among millennials - 2025 Buyback Activity & Consistent Return Investment Signals fcp.pa.gov.br
Published: Nov. 6, 2025, 9:20 a.m.
Cannabis-Based Medicines in Women’s Health: Evidence & Knowledge Gaps - Cannabis Health News
Cannabis-Based Medicines in Women’s Health: Evidence & Knowledge Gaps Cannabis Health News
Published: Nov. 6, 2025, 9:03 a.m.
Proteomics International Secures Grant for Endometriosis Diagnostic Test - TipRanks
Proteomics International Secures Grant for Endometriosis Diagnostic Test TipRanks
Published: Nov. 6, 2025, 8:43 a.m.
Here’s what every woman should know about cycle syncing - Vogue Singapore
Here’s what every woman should know about cycle syncing Vogue Singapore
Published: Nov. 6, 2025, 8:16 a.m.
Will Ashland Inc. stock outperform value stocks - M&A Rumor & Verified Short-Term Trading Plans - fcp.pa.gov.br
Will Ashland Inc. stock outperform value stocks - M&A Rumor & Verified Short-Term Trading Plans fcp.pa.gov.br
Published: Nov. 6, 2025, 7:45 a.m.
Proteomics International Receives AU$500,000 Western Australia Grant to Help Commercialize Endometriosis Blood Test - MarketScreener
Proteomics International Receives AU$500,000 Western Australia Grant to Help Commercialize Endometriosis Blood Test MarketScreener
Published: Nov. 6, 2025, 6:30 a.m.
HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health - Fidelity
HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health Fidelity
Published: Nov. 6, 2025, 4:32 a.m.
Link copied to clipboard!